ColoSeal™ ICD System Safety and Feasibility Studies
NCT: NCT06402188 · ACTIVE_NOT_RECRUITING
Brief Summary
The studies aim to evaluate the safety and feasibility of the ColoSeal Intraluminal Colonic Diversion (ICD) System in two prospective, multicenter, single-arm studies. The ColoSeal ICD System is intended to be used to protect a damaged segment of colon such as a surgical anastomosis, anastomosis leak, or perforation from contact with fecal flow for up to 14 days. The device will be evaluated in adult patients with rectal and rectosigmoid cancer undergoing a resection with a colorectal anastomosis.
Frequently Asked Questions
What is ColoSeal™ ICD System Safety and Feasibility Studies?
ColoSeal™ ICD System Safety and Feasibility Studies is a clinical trial registered under NCT06402188. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06402188?
The current status of NCT06402188 (ColoSeal™ ICD System Safety and Feasibility Studies) is: ACTIVE_NOT_RECRUITING.
When did ColoSeal™ ICD System Safety and Feasibility Studies start?
ColoSeal™ ICD System Safety and Feasibility Studies started on 2023-06-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.